Tow Center for Developmental Oncology (TCDO)

People

  1. Morris
    Morris
  2. Boelens
    Boelens
  3. O'Reilly
    O'Reilly
  4. Joyner
    Joyner
  5. Finley
    Finley
  6. Sawyers
    Sawyers
  7. Tabar
    Tabar
  8. Mellinghoff
    Mellinghoff
  9. Klebanoff
    Klebanoff
  10. Lim
    Lim
  11. Kentsis
    Kentsis
  12. Antonescu
    Antonescu
  13. Kharas
    Kharas
  14. Baylies
    Baylies
  15. Ladanyi
    Ladanyi

Description

Publications

  1. Blood (815)
  2. Journal of Clinical Oncology (503)
  3. Modern Pathology (314)
  4. Cancer Research (294)
  5. Laboratory Investigation (274)
  6. Neuro-Oncology (242)
  7. Clinical Cancer Research (230)
  8. Biology of Blood and Marrow Transplantation (177)
  9. Genes Chromosomes and Cancer (125)
  10. American Journal of Surgical Pathology (120)

Publishers

  1. Nature Publishing Group (892)
  2. American Society of Hematology (882)
  3. Elsevier Inc. (647)
  4. American Society of Clinical Oncology (551)
  5. American Association for Cancer Research (524)
  6. Oxford University Press (357)
  7. Nature Research (327)
  8. Lippincott Williams & Wilkins (293)
  9. Cell Press (283)
  10. Springer (257)

Types of Work

Recent Works

  1. The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: A RANO perspective
    Review

    van den Bent, M. J.; Cloughesy, T. F.; Ellingson, B. M.; Allen, J. E.; Blackman, S. C.; Kieran, M. W.; Tonn, J. C.; Karschnia, P.; Wijnenga, M.; Pallud, J.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  2. Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma
    Journal Article

    Schaff, L. R.; Piotrowski, A. F.; Pentsova, E.; Gavrilovic, I. T.; Lin, A.; Kaley, T. J.; Wongchai, V.; Emadi-Paramkouhi, L.; Madzsar, J.; Quinn, L.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  3. Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma
    Journal Article

    Souweidane, M. M.; Bander, E. D.; Zanzonico, P.; Reiner, A. S.; Manino, N.; Haque, S.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Lewis, J. S.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save